Why Choose HIFU

Every man with prostate cancer is uniquely different. Several variables need to be considered when discussing appropriate treatment options. The overall health of the patient needs to be considered. The Gleason’s score, clinical stage and prostate volume need to be known. Also, and most importantly, what are the desires and goals of the patient? This discussion should also include an in-depth presentation of the multiple treatment options available for prostate cancer, including their risks, benefits and outcomes. Only then, can an individual truly make an informed decision.

HIFU is a relatively new option for the treatment of prostate cancer. It has already been used in various fields of medicine to treat a number of ailments. As technology advances, so does our ability to improve the quality of health care provided to our patients. Since there is no single treatment option for prostate cancer that meets the needs of all patients, doctors have continued to strive to find new treatment modalities that will meet these demands.

The Sonablate® 500 is being studied in clinical trials for use in the treatment of prostate cancer in the United States and is not approved for use by the U.S. Food and Drug Administration. HIFU with the Sonablate® 500 is authorized for use for the treatment of prostate cancer in Canada, Argentina and the Dominican Republic. It is also available in the Bahamas and Mexico.